SOPH logo

SOPHiA GENETICS SA (SOPH) Company Overview

Profile

Full Name:

SOPHiA GENETICS SA

Sector:

Healthcare

Industry:

Health Information Services

Country:

Switzerland

IPO:

July 23, 2021

Indexes:

Not included

Website:

http://www.sophiagenetics.com

Description:

SOPH (SOPHiA GENETICS SA) is a biotechnology company that uses data-driven medicine to improve patient care. They provide advanced genomic analysis tools to help doctors diagnose diseases and personalize treatments, making healthcare more effective and accessible for patients worldwide.

Key Details

Price

$3.95

Market Cap

$262.43 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$62.37 M(+31.14% YoY)

Annual EPS

-$1.22(+10.29% YoY)

PE Ratio

-

Annual ROE

-44.93%

Annual Debt To Equity

0.00

Beta

0.28

Events Calendar

Earnings

Next earnings date:

Mar 4, 2025

Recent quarterly earnings:

Nov 5, 2024

Recent annual earnings:

Mar 5, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 18, 24 Craig-Hallum
Buy
Aug 7, 24 RBC Capital
Outperform
Jun 27, 24 Guggenheim
Buy
Mar 6, 24 RBC Capital
Outperform
Mar 6, 24 BTIG
Buy
Jan 12, 24 RBC Capital
Outperform
Nov 29, 23 RBC Capital
Outperform
May 10, 23 Morgan Stanley
Overweight
May 10, 23 Credit Suisse
Neutral
Mar 8, 23 Morgan Stanley
Overweight

Screeners with SOPH included

Growing Shares Outstanding
Biggest stock losers today
Most recommended stocks
Best performing stocks last 3 months
Stocks above SMA 50
Stocks below analysts price target
Healthcare sector
All stocks
Small cap stocks
Stocks with low beta

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$3.95
SOPH price is $3.95

Price All-time High

$19.77
SOPH price is currently -80.02% below its historical high of $19.77

Price Analysts Target

$6.00
SOPH price is currently -34.17% lower than the consensus analysts' forecast

Price Most Recent Change

-7.49%
SOPH price was down -7.49% on Feb 22, 2025

Price YTD Change

+28.66%
SOPH price is up +28.66% since January 1st

Price 3-Year Change

-66.09%
SOPH price is down -66.09% over the past 3 years

Market cap

Market Cap

$262.43 M
SOPH market capitalization is $262.43 million

Market Cap 3-Year Change

-64.75%
SOPH market capitalization is down -64.75% over the past 3 years

Market Cap All-time High

$1.26 B
SOPH market capitalization is currently -79.21% below its historical high of $1.26 billion

Market Cap Sector Rank

58.54%
SOPH market capitalization is higher than 58.54% of companies in Healthcare sector

Technical

Beta

0.28
SOPH beta is 0.28

200-day SMA

$3.92
SOPH price is currently +0.64% above its 200-day simple moving average

14-day RSI

53.80
SOPH 14-day relative strength index is 53.80

30-day Relative Volume

0.71
SOPH 30-day relative volume is 0.71

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$62.37 M
SOPH annual revenue is $62.37 million

Annual Revenue Analysts Estimate

$65.14 M
SOPH annual revenue is currently -4.25% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+31.14%
SOPH annual revenue is up +31.14% year-on-year

Annual Revenue Sector Rank

50.78%
SOPH annual revenue is higher than 50.78% of companies in Healthcare sector

Profit

Annual Gross Profit

$42.91 M
SOPH annual gross profit is $42.91 million

Annual Gross Margin

68.80%
SOPH annual gross profit margin is 68.80%

Annual Operating Profit

-$74.83 M
SOPH annual operating income is -$74.83 million

Annual Operating Margin

-119.97%
SOPH annual operating profit margin is -119.97%

Annual Net Income

-$78.98 M
SOPH annual net profit is -$78.98 million

Annual Net Margin

-126.63%
SOPH annual net profit margin is -126.63%

EPS

Annual EPS

-$1.22
SOPH annual earnings per share is -$1.22

Annual EPS Analysts Estimate

-$0.76
SOPH annual earnings per share is currently +61.59% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+10.29%
SOPH annual earnings per share is up +10.29% year-on-year

Annual EPS Sector Rank

56.32%
SOPH annual earnings per share is higher than 56.32% of companies in Healthcare sector

ROA & ROE

Annual ROA

-35.10%
SOPH annual return on assets is -35.10%

Annual ROE

-44.93%
SOPH annual return on equity is -44.93%

EBIT & EBITDA

Annual EBIT

-$77.91 M
SOPH annual earnings before interest & taxes is -$77.91 million

Annual EBITDA

-$69.57 M
SOPH annual EBITDA is -$69.57 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
SOPH price to earnings ratio value is unknown

PE Ratio Sector Rank

-
SOPH price to earnings ratio is unknown

PB Ratio

PB Ratio

2.31
SOPH price to book ratio is 2.31

PB Ratio Sector Rank

62.41%
SOPH price to book ratio is higher than 62.41% of companies in Healthcare sector

PS Ratio

PS Ratio

4.07
SOPH price to sales ratio is 4.07

PS Ratio Sector Rank

55.66%
SOPH price to sales ratio is higher than 55.66% of companies in Healthcare sector

Enterprise value

Enterprise Value

$198.32 M
SOPH enterprise value is $198.32 million

Enterprise Value Sector Rank

57.93%
SOPH enterprise value is higher than 57.93% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.15
SOPH EV/EBITDA is -3.15

EV/EBITDA Sector Rank

31.09%
SOPH EV/EBITDA is higher than 31.09% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.16
SOPH annual current ratio is 4.16

Annual Quick Ratio

3.97
SOPH annual quick ratio is 3.97

Leverage

Annual Debt To Equity

0.00
SOPH annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-132.49
SOPH annual interest coverage ratio is -132.49

Risk & Stability

Piotroski F-Score

2
SOPH piotroski f-score is 2

Altman Z-Score

0.02
SOPH altman z-score is 0.02

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$206.16 M
SOPH annual total assets is $206.16 million

Annual Non Current Assets

$58.11 M
SOPH annual long term assets is $58.11 million

Annual Current Assets

$148.05 M
SOPH annual total current assets is $148.05 million

Annual Cash & Cash Equivalents

$123.25 M
SOPH annual cash & cash equivalents is $123.25 million

Equity

Annual Book Value

$151.44 M
SOPH annual book value is $151.44 million

Annual Working Capital

$112.43 M
SOPH annual working capital is $112.43 million

Liabilities

Annual Total Liabilities

$54.71 M
SOPH annual total liabilities is $54.71 million

Annual Total Long Term Liabilities

$19.09 M
SOPH annual total long term liabilities is $19.09 million

Annual Current Liabilities

$35.62 M
SOPH annual total current liabilities is $35.62 million

Annual Accounts Payable

$2.26 M
SOPH annual accounts payable is $2.26 million

Debt

Annual Total Debt

$18.60 M
SOPH annual total debt is $18.60 million

Annual Total Debt 1-Year Change

+11.1%
SOPH annual total debt is up +11.1% year-on-year

Annual Long Term Debt

$15.67 M
SOPH annual long term debt is $15.67 million

Annual Short Term Debt

$2.93 M
SOPH annual short term debt is $2.93 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$137.20 M
SOPH annual total expenses is $137.20 million

Annual Operating Expenses

$117.74 M
SOPH annual total operating expenses is $117.74 million

Annual Cost Of Goods Sold

$19.46 M
SOPH annual cost of goods sold is $19.46 million

Annual SGA

$81.72 M
SOPH annual SGA is $81.72 million

Annual D&A

$8.34 M
SOPH annual depreciation & amortization is $8.34 million

Annual Interest Expense

$588.00 K
SOPH annual interest expense is $588.00 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$48.58 M
SOPH annual cash flow from operations is -$48.58 million

Annual CFO 1-Year Change

+30.7%
SOPH annual cash flow from operations is up +30.7% year-on-year

Annual CFI

$8.32 M
SOPH annual cash flow from investing activities is $8.32 million

Annual CFI 1-Year Change

-80.18%
SOPH annual cash flow from investing activities is down -80.18% year-on-year

Annual CFF

-$2.82 M
SOPH annual cash flow from financing activities is -$2.82 million

Annual CFF 1-Year Change

-79.66%
SOPH annual cash flow from financing activities is down -79.66% year-on-year

Free CashFlow

Annual FCF

-$57.80 M
SOPH annual free cash flow is -$57.80 million

Annual FCF 1-Year Change

+28.17%
SOPH annual free cash flow is up +28.17% year-on-year

CAPEX

Annual CAPEX

$9.23 M
SOPH annual capital expenditures is $9.23 million

Annual CAPEX 1-Year Change

-11.13%
SOPH annual capital expenditures is down -11.13% year-on-year

Institutional Ownership

Similar stocks

ABEO logo
Abeona Therapeutics (ABEO)
ACIU logo
AC Immune SA (ACIU)
Acelyrin (SLRN)
STIM logo
Neuronetics (STIM)
HRTX logo
Heron Therapeutics (HRTX)
VSTM logo
Verastem (VSTM)
NGNE logo
Neurogene (NGNE)
LXRX logo
Lexicon Pharmaceuticals (LXRX)
Palvella Therapeutics (PVLA)

FAQ

  • What is the ticker symbol for SOPHiA GENETICS SA?
  • Does SOPHiA GENETICS SA pay dividends?
  • What sector is SOPHiA GENETICS SA in?
  • What industry is SOPHiA GENETICS SA in?
  • What country is SOPHiA GENETICS SA based in?
  • When did SOPHiA GENETICS SA go public?
  • Is SOPHiA GENETICS SA in the S&P 500?
  • Is SOPHiA GENETICS SA in the NASDAQ 100?
  • Is SOPHiA GENETICS SA in the Dow Jones?
  • When was SOPHiA GENETICS SA's last earnings report?
  • When does SOPHiA GENETICS SA report earnings?
  • Should I buy SOPHiA GENETICS SA stock now?

What is the ticker symbol for SOPHiA GENETICS SA?

The ticker symbol for SOPHiA GENETICS SA is NASDAQ:SOPH

Does SOPHiA GENETICS SA pay dividends?

No, SOPHiA GENETICS SA does not pay dividends

What sector is SOPHiA GENETICS SA in?

SOPHiA GENETICS SA is in the Healthcare sector

What industry is SOPHiA GENETICS SA in?

SOPHiA GENETICS SA is in the Health Information Services industry

What country is SOPHiA GENETICS SA based in?

SOPHiA GENETICS SA is headquartered in Switzerland

When did SOPHiA GENETICS SA go public?

SOPHiA GENETICS SA's initial public offering (IPO) was on July 23, 2021

Is SOPHiA GENETICS SA in the S&P 500?

No, SOPHiA GENETICS SA is not included in the S&P 500 index

Is SOPHiA GENETICS SA in the NASDAQ 100?

No, SOPHiA GENETICS SA is not included in the NASDAQ 100 index

Is SOPHiA GENETICS SA in the Dow Jones?

No, SOPHiA GENETICS SA is not included in the Dow Jones index

When was SOPHiA GENETICS SA's last earnings report?

SOPHiA GENETICS SA's most recent earnings report was on Nov 5, 2024

When does SOPHiA GENETICS SA report earnings?

The next expected earnings date for SOPHiA GENETICS SA is Mar 4, 2025

Should I buy SOPHiA GENETICS SA stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions